Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Azathioprine MeSH Descriptor Data 2026


MeSH Heading
Azathioprine
Tree Number(s)
D02.886.759.111
D03.633.100.759.570.090
D13.570.900.111
Unique ID
D001379
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D001379
Scope Note
An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
Entry Term(s)
Azathioprine Sodium
Azathioprine Sodium Salt
Azathioprine Sulfate
Azothioprine
Immuran
Imuran
Imurel
Pharm Action
Antimetabolites
Antimetabolites, Antineoplastic
Immunosuppressive Agents
Antirheumatic Agents
Registry Numbers
MRK240IY2L
0
55372-48-0
AM94R510MS
Related Numbers
446-86-6
55372-48-0
AM94R510MS
CAS Type 1 Name
1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-
Public MeSH Note
66
History Note
66(64)
Date Introduced
1966/01/01
Last Updated
2018/07/05
Azathioprine Preferred
Imuran Narrower
Imurel Narrower
Azathioprine Sulfate Narrower
Azathioprine Sodium Narrower
page delivered in 0.148s